Search Results

There are 32473 results for: content related to: Statins of high versus low cholesterol-lowering efficacy and the development of severe renal failure

  1. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  2. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  3. Is the Quebec provincial administrative database a valid source for research on chronic non-cancer pain?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 9, September 2015, Pages: 980–990, Anaïs Lacasse, Mark A. Ware, Marc Dorais, Hélène Lanctôt and Manon Choinière

    Version of Record online : 24 JUN 2015, DOI: 10.1002/pds.3820

  4. Metformin therapy and kidney disease: a review of guidelines and proposals for metformin withdrawal around the world

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1027–1035, Farshad Kajbaf, Paul Arnouts, Marc de Broe and Jean-Daniel Lalau

    Version of Record online : 19 AUG 2013, DOI: 10.1002/pds.3501

  5. Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 489–497, Supinya Dechanont, Sirada Maphanta, Bodin Butthum and Chuenjid Kongkaew

    Version of Record online : 10 MAR 2014, DOI: 10.1002/pds.3592

  6. You have full text access to this OnlineOpen article
    Methodological gaps in the assessment of risk minimization interventions: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 572–579, Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise and Yola Moride

    Version of Record online : 24 FEB 2014, DOI: 10.1002/pds.3596

  7. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  8. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 28 JAN 2016, DOI: 10.1002/pds.3966

  9. Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 12, December 2015, Pages: 1259–1270, Diogo Mendes, Carlos Alves and Francisco Batel-Marques

    Version of Record online : 16 SEP 2015, DOI: 10.1002/pds.3874

  10. Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 7, July 2014, Pages: 667–678, Shahrul Mt-Isa, Christine E. Hallgreen, Nan Wang, Torbjörn Callréus, Georgy Genov, Ian Hirsch, Stephen F. Hobbiger, Kimberley S. Hockley, Davide Luciani, Lawrence D. Phillips, George Quartey, Sinan B. Sarac, Isabelle Stoeckert, Ioanna Tzoulaki, Alain Micaleff, Deborah Ashby and On behalf of the IMI-PROTECT benefit–risk participants

    Version of Record online : 13 MAY 2014, DOI: 10.1002/pds.3636

  11. You have full text access to this OnlineOpen article
    Comparative effectiveness of rosuvastatin versus simvastatin in primary prevention among new users: a cohort study in the French national health insurance database

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 240–250, Anke Neumann, Géric Maura, Alain Weill, Philippe Ricordeau, François Alla and Hubert Allemand

    Version of Record online : 2 DEC 2013, DOI: 10.1002/pds.3544

  12. Ophthalmic adverse drug reactions to systemic drugs: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 221–233, Ana Miguel, Filipe Henriques, Luís Filipe Azevedo and Altamiro Costa Pereira

    Version of Record online : 27 JAN 2014, DOI: 10.1002/pds.3566

  13. Case-crossover study design in pharmacoepidemiology: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Pages: 1146–1153, Giulia P. Consiglio, Andrea M. Burden, Malcolm Maclure, Lisa McCarthy and Suzanne M. Cadarette

    Version of Record online : 13 SEP 2013, DOI: 10.1002/pds.3508

  14. Literature review of visual representation of the results of benefit–risk assessments of medicinal products

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 238–250, Christine E. Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, Lawrence D. Phillips, Diana Hughes, Susan Talbot, Alex Asiimwe, Gerald Downey, Georgy Genov, Richard Hermann, Rebecca Noel, Ruth Peters, Alain Micaleff, Ioanna Tzoulaki, Deborah Ashby and On behalf of PROTECT Benefit–Risk group

    Version of Record online : 2 NOV 2015, DOI: 10.1002/pds.3880

  15. A critical review of methods to evaluate the impact of FDA regulatory actions

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 986–994, Becky A. Briesacher, Stephen B. Soumerai, Fang Zhang, Sengwee Toh, Susan E. Andrade, Joann L. Wagner, Azadeh Shoaibi and Jerry H. Gurwitz

    Version of Record online : 12 JUL 2013, DOI: 10.1002/pds.3480

  16. Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 961–969, Ruth Cunill, Xavier Castells, Aurelio Tobias and Dolors Capellà

    Version of Record online : 30 JUN 2013, DOI: 10.1002/pds.3473

  17. Application of marginal structural models in pharmacoepidemiologic studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 6, June 2014, Pages: 560–571, Shibing Yang, Charles B. Eaton, Juan Lu and Kate L. Lapane

    Version of Record online : 24 JAN 2014, DOI: 10.1002/pds.3569

  18. You have full text access to this OnlineOpen article
    Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 559–570, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Francesco Salvo, Federica Nicotra, Miriam Sturkenboom and Susana Perez-Gutthann

    Version of Record online : 25 APR 2013, DOI: 10.1002/pds.3437

  19. Selection bias in pharmacy-based patient surveys

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 128–139, P Frisk, S Kälvemark-Sporrong and B Wettermark

    Version of Record online : 30 AUG 2013, DOI: 10.1002/pds.3488

  20. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 5, May 2016, Pages: 521–538, Louisa Degenhardt, Natasa Gisev, Elena Cama, Suzanne Nielsen, Briony Larance and Raimondo Bruno

    Version of Record online : 19 JAN 2016, DOI: 10.1002/pds.3931